http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0628820-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75fcfb61e8c9c1c77d86ee7363827081
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
filingDate 1994-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b431ecab411385c60b75301067b0bce9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394436e2c26af1d272e998a810b21623
publicationDate 1995-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0628820-A3
titleOfInvention Diagnosis and monitoring of colon cancer patients by measuring CAS 50/90 in the blood.
abstract A method for aiding in the diagnosis of, and monitoring the progression or course of, colon cancer in a patient by measuring the amount of NCA 50/90 in a blood sample, e.g., serum sample, obtained from the patient. Measurement in a single sample of an amount of NCA 50/90 significantly higher than the mean amount of NCA 50/90 in the normal population is an indication of colon cancer in a symptomatic patient. The course of colon cancer can also be monitored by performing a series of specific immunoassays over time to determine changes in the level of NCA 50/90 in blood samples. Increases in blood NCA 50/90 levels over time are indicative of a deteriorating condition whereas decreasing levels of blood NCA 50/90 over time indicate an improving condition.
priorityDate 1993-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0549974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0446602-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129763036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128191510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378

Total number of triples: 22.